Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90α Inhibitors

Abstract

A series of novel substituted 2-pyrimidylbenzothiazoles incorporating either sulfonamide moieties or the amino group at C2 of the pyrimidine ring were synthesized and evaluated for its antiviral potency. The novel synthesis of the ring system was carried out by reacting guanidine or N-arylsulfonated guanidine with different derivatives of ylidene benzothiazole based on Michael addition pathways. The antiviral activity of the newly synthesized compounds was examined by a plaque reduction assay against HSV-1, CBV4, HAV HM 175, HCVcc genotype 4 viruses, and HAdV7. In the case of HSV-1, it was determined that 5 out of the 21 synthesized compounds exhibited superior viral reduction in the range of 70−90% with significant IC 50 , CC 50 , and SI values as compared with acyclovir. In the case of CBV4, nine compounds have shown more than 50% reduction. Comparable results were obtained for seven of these synthesized compounds when evaluated against HAV with only a couple of them showing 50% reduction or more against HCVcc genotype 4. Remarkably, one compound, 9a, has shown broad action against all five examined viruses, rendering it as potentially an effective antiviral agent. The five potent compounds 9a, 9b, 14b, 14g, and 14h against HSV-1 have also presented inhibitory activity against the Hsp90α protein with IC 50 in the range of 4.87−10.47 μg/mL. Interestingly, a combination of the potent synthesized compounds with acyclovir led to IC 50 values lower than that of acyclovir alone. The potent compounds 9a, 9b, 14b, 14g, and 14h were also docked inside the active site of Hsp90α to assess the interaction pattern between the tested compounds and the active site of the protein.

Discovery of potent Covid‐19 main protease inhibitors using integrated drug‐repurposing strategy

“…Notably, sulfonamides moieties can act as potential medicinal molecules in drug discovery and drug development with a broad spectrum of biological applications. 41,42 Of interest here, it has been shown on many occasions that sulfonamide structural units present within various molecules have exhibited interesting antiviral activities. The presence of sulfonamide scaffold within the various molecules is a common factor among the active compounds for combating different infectious viruses.…”

Synthesis and Evaluation of Some Uracil Nucleosides as Promising Anti-Herpes Simplex Virus 1 Agents

“… Some potent cyclic and acyclic nucleoside analogues used as potent anti-viral agents [ 19 , 20 , 21 , 22 , 23 ]. …”

“…The chemical structures of some of the drugs mentioned above, together with other potent anti-viral agents belonging to the class of cyclic and acyclic nucleoside analogues, are discussed in Figure 1. [19][20][21][22][23]. Figure 1.…”

An Updated Overview of Herpes Simplex Virus-1 Infection: Insights from Origin to Mitigation Measures

“…Moreover, a newly synthesized compound 2pyrimidyl benzothiazole derivatives exhibit antiviral activities and inhibitory effect on Hsp90α protein. Thus, it has the potential to use as an effective broad-spectrum antiviral agent [156]. Here, X sign states on which phase the vaccine is now on; X(T), X(P), and X(P & T) sign refers to either the vaccine is therapeutic types, preventive types, or both respectively; POC refers as Proof of Concept Trial.…”